RA CAPITAL MANAGEMENT, L.P. Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$1.2T
Holdings
27
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,512,049 | $263.7B | 22.06% | |
| 2 | ASNDASCENDIS PHARMA A S | 5,580,690 | $223.6B | 18.71% | |
| 3 | —AVEXIS INC | 1,171,278 | $129.6B | 10.85% | |
| 4 | SG7SAGE THERAPEUTICS INC | 455,173 | $75.0B | 6.27% | |
| 5 | IFRXINFLARX NV | 2,876,080 | $60.3B | 5.04% | |
| 6 | —BIOHAVEN PHARMACTL HLDG CO LTD | 1,997,278 | $53.9B | 4.51% | |
| 7 | —ZOGENIX INC | 1,145,268 | $45.9B | 3.84% | |
| 8 | —DICERNA PHARMACEUTICALS INC | 4,965,513 | $44.8B | 3.75% | |
| 9 | KALAKALA PHARMACEUTICALS INC | 2,113,236 | $39.1B | 3.27% | |
| 10 | —MYOVANT SCIENCES LTD | 2,830,455 | $35.8B | 2.99% | |
| 11 | SCPHSCPHARMACEUTICALS INC | 2,857,143 | $34.5B | 2.89% | |
| 12 | BCRXBIOCRYST PHARMACEUTICALS | 6,984,692 | $34.3B | 2.87% | |
| 13 | —KADMON HLDGS INC | 6,269,342 | $22.7B | 1.90% | |
| 14 | APLSAPELLIS PHARMACEUTICALS INC | 900,000 | $19.5B | 1.63% | |
| 15 | SPROSPERO THERAPEUTICS INC | 1,225,647 | $14.4B | 1.20% | |
| 16 | —ENDOCYTE INC | 3,364,648 | $14.4B | 1.20% | |
| 17 | —AVEO PHARMACEUTICALS INC | 5,062,759 | $14.1B | 1.18% | |
| 18 | KALVKALVISTA PHARMACEUTICALS INC | 1,441,070 | $14.1B | 1.18% | |
| 19 | —RA PHARMACEUTICALS INC | 1,351,808 | $11.5B | 0.96% | |
| 20 | —SUNESIS PHARMACEUTICALS INC | 3,096,840 | $11.4B | 0.96% | |
| 21 | —CLEMENTIA PHARMACEUTICALS INC COM NPV | 585,403 | $11.1B | 0.93% | |
| 22 | KRYSKRYSTAL BIOTECH INC | 700,000 | $7.4B | 0.62% | |
| 23 | ARGXARGENX SE | 75,816 | $4.8B | 0.40% | |
| 24 | GTHXEURG1 THERAPEUTICS INC | 159,780 | $3.2B | 0.27% | |
| 25 | —PROTEON THERAPEUTICS INC | 1,337,462 | $2.5B | 0.21% | |
| 26 | —CHIASMA INC | 1,176,806 | $2.0B | 0.17% | |
| 27 | —ACHILLION PHARMACEUTICALS INC | 585,890 | $1.7B | 0.14% |